Company intelligence / Profile preview
Shanghai Yuzhihua Pharmaceutical Technology
- Ownership
- Private
- Development stage
- Other
Overview
Shanghai Yuzhihua Pharmaceutical Technology is a clinical-stage biopharmaceutical company dedicated to the discovery and development of next-generation small molecule therapeutics. The company focuses on targeting the DNA damage response (DDR) pathway and protein degradation mechanisms to treat oncology and autoimmune conditions. Its lead candidate, YZH-101, is a highly selective USP1 inhibitor currently in Phase 1 clinical trials for patients with advanced solid tumors. Headquartered in Shanghai, the company is backed by prominent venture capital firms and led by an experienced team of drug discovery experts.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Shanghai Yuzhihua Pharmaceutical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Yuzhihua Pharmaceutical Technology.